The Survival and Its Associated Factors among Patients with Diabetic Kidney Disease on continuous Ambulatory Peritoneal Dialysis: Three-Year Experience in Maharat Nakhon Ratchasima Hospital

Main Article Content

Waraporn Liawnoraset
Suchart Jenkriangkrai
Warunee Svetamal
Sirilak Suttharattanakun

Abstract

          Objective: To evaluate the patient survival and the influencing factors in continuous ambulatory peritoneal dialysis (CAPD) patients with diabetic kidney disease at Maharat Nakhon Ratchasima Hospital. Patients & Methods: Medical records of diabetic CAPD patients in Maharat Nakhon Ratchasima Hospital during January 1, 2008-December 31, 2010 were reviewed. The collected data included demographic details, underlying diseases, body mass index (BMI), laboratory findings, peritonitis episodes, and outcome of therapy on December 31, 2010. Results: One hundred and  eleven diabetic CAPD patients were analysed. There were 57.7% male, mean age was 51.9 ± 14.4 year (Range 15.3-78.6 year). The CAPD patients had anemia (67.3%), hypokalemia (36.3%) and hypoalbuminemia (66.3%). In the follow up period, total observation period was 977.4 patient-months. Patient survivals at 1, 2 and 3 years were 64.4%, 47.5% and 47.5%, respectively. The mean patient survival time was 25.6 months. The influencing factors that lowered patient survival were age above 60 years, serum potassium below 3.5 mEq/L and serum albumin <3.5 g/dL. Peritonitis rate was 21.2 patient-months per episode. Streptococcus spp. and Staphylococcus aureus were common causative organisms. Mean patient survival in no-peritonitis group was higher than peritonitis group, without statistic significance. At the end of study, the patients continued on CAPD (60.2%), switched to hemodialysis (4.6%) were referred to another center (0.9%), and died (34.3%). Conclusion:  Diabetic CAPD patients had had high incidences of hypokalemia and hypoalbuminemia that influenced the survival of these patients. The peritonitis was not significant influencing factors for patient survival. So there was importance to improve patient survival by correcting the influencing factors and nutritional status in diabetic CAPD patients.

Article Details

How to Cite
Liawnoraset, W., Jenkriangkrai, S., Svetamal, W., & Suttharattanakun, S. (2024). The Survival and Its Associated Factors among Patients with Diabetic Kidney Disease on continuous Ambulatory Peritoneal Dialysis: Three-Year Experience in Maharat Nakhon Ratchasima Hospital. Maharat Nakhon Ratchasima Hospital Journal, 35(1), 13–22. Retrieved from https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/1722
Section
Original Article

References

Perkovic V, Cass A, Patel AA, Suriyawongpaisal P, Barzi F, Chadban S, et al. High prevalence of chronic kidney disease in Thailand. Kidney Int 2008; 73: 473-9.

Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-47.

National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratication: update 2002. Am I Kidney Dis 2002;39: S1- S266.

Peritoneal Dialysis Adequacy Work Group. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 2006; 48: S98-S129.

Huang CC, Cheng KF, Wu HD. Survival analysis comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int 2008; 28: S15-S20.

Stack AG, Murthy BV, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int 2004; 65: 2398-408.

Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int 2001; 21: 148-53.

Johnson JG, Gore SM, Fith J. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: a systematic quantitative overview of the liturature. Nephrol Dial Transplant 1999; 14: 2156-64.

Stein G, Funfstuck R, Schiel R. Diabetes mellitus and dialysis. Minerva Urol Nefrol 2004; 56: 289-303.

Liawnoraset W, Jenkriangkrai S, Kanokkantapong C, Svetamal W, Suttharattanakun S. The outcome of continuous ambulatory peritoneal dialysis therapy under the universal coverage scheme in Maharat Nakhon Ratchasima Hospital: the first year of peritoneal dialysis policy. Maharat Nakhon Ratchasima Hosp Med Bull 2010; 34: 25-31.

Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA, et al. Serum albumin: a marker for morbidity in peritoneal dialysis patients. Am I Kidney Dis 1993; 21: 26-30.

Pongskul C, Sirivongs D, Keobounma T, Chanlertrith D, Promajuk P, Limwatananon C. Survival and technical failure in a large cohort of Thai CAPD patients. Med Assoc Thai 2006; 89: S98-S105.

Prasad N, Gupta A, Sinha A, Singh A, Sharma RK, Kumar A, etal. A comparison of outcomes between diabetic and nondiabetic CAPD patients in India. Perit Dial Int 2008; 28: 468-76.

Abbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RM. Body mass index and peritoneal dialysis: "exceptions to the exception" in reverse epidemiology?Semin Dial 2007; 20: 561-5.

McDonald SP, Collins JF, Rumpsfeld M, JohnsonDW. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoncal dialysis patient populations. Perit Dial Int 2004; 24: 340-6.

Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, LiPK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 2005; 25:374-9.

Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 2003; 41:664-9.

Sirivongs D, Pongskul C, Keobounma T, Chunlertrith D, Sritaso K, Johns J. Risk factors of first peritis episode in Thai CAPD patients. J Med Assoc Thai 2006; 89: S138-S145.

Harty J, Gokal R. Nutritional status in peritoneal dialysis. J Renal Nutr 1995; 5: 2-10.

Choo V. WHO reassesses appropriate body-mass index for Asian populations. The Lancet 2002; 360: 235.

WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-63.

Espinosa A, Cueto-Manzano AM, Velazquez-Alva C, Hernandez A, Cruz N, Zamora B, et al. Prevalence of malnutrition in Mexican CAPD diabetic and nondiabetic patients. Adv Perit Dial 1996; 12:302-6.

Prasad N, Gupta A, Sinha A, Sharma RK, Saxena A, Kaul A, et al. Confounding effect of comorbidities and malnutrition on survival of peritoneal dialysis patients. Renal Nutrition 2010; 20: 384-91.

Nakamoto H, Suzuki H; Japan PDC Study Group. Hypoproteinemia in patients with diabetes undergoing continuous ambulatory peritoneal dialysis is attributable to high permeability of peritoncal membrane. Perit Dial Int 2003; 23: S72-S78.

Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi I, Kumon S, et al. Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD. Am J Kidney Dis 2002; 40: 1023-54.

Pliakogiannis T. Trpeski L, Taskapan Hah H, Ahmad M, Fenton S, et al. Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature. Int Urol Nephrol 2007; 39: 281-8.

Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lec HY. Clinical outcome in continuous ambulatory peritoneal dialysis patients is not influenced by high peritoncal transport status. Perit Dial Int 2001; 21: S80-S85.